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Abstract: 
 
Background and aims: Adverse drug events (ADEs) are a major cause of morbidity and mortality, with 
more than 50% of ADEs being preventable. Adverse Drug Reactions (ADRs) are typically the result of 
an incomplete medication history, prescribing or dispensing error, as well as over- or under-use of 
prescribed pharmacotherapy. Medication reconciliation is the process of creating the most accurate list 
of medications a patient is taking and subsequently comparing the list against the different transitions 
of care. It is used to reduce medication discrepancies, and thereby ultimately decreasing ADEs. 
However, little is known about medicine reconciliation activities among public hospitals in South Africa. 
Methods: Prospective quantitative, descriptive design among Internal and Surgical wards in a leading 
public hospital in South Africa. Results: 145 study participants were enrolled. Over 1300 (1329) 
medicines were reviewed of which there was a significant difference (p=0.006) when comparing the 
medications that the patient was taking before or during hospitalisation. A total of 552 (41.53%) 
interventions were undertaken and the majority of patients had at least 3.96 medication discrepancies. 
The most common intervention upon admission was transcribing the home medication onto the hospital 
prescription (65.2%) followed by medication duplication (13.44%). During SDWLHQW¶V hospital stay, 
interventions included patient counselling (32.5%) and stopping the previous treatment (37.5%). 
Conclusion: To ensure continuity of patient care, medication reconciliation should be implemented 
WKURXJKRXWSDWLHQWV¶KRVSLWDOVWD\. This involves all key professionals in hospitals.  
 
Keywords: 
MEDICATION RECONCILIATION, MEDICATION ERRORS, PHARMACEUTICAL CARE, SOUTH 
AFRICA. 
 
1. Introduction  
 
South Africa has a progressive constitution (1), which states that every citizen has the right to access 
quality healthcare. To ensure this realisation, the National Department of Health (NDoH) in 2011 
developed national core standards (NCS) for patient safety, which describes what a hospital or clinic 
must do to make sure that patients are respected and their rights upheld, including getting access to 
needed care (2,3), serving as an exemplar to other African countries where there are concerns with 
initiatives in practice to enhance the rational use of medicines (4-7).  Furthermore, SDWLHQWV¶ VDIHW\
concerns prompted the World Health Organisation (WHO) to form a patient safety program in response 
WRD:RUOG+HDOWK$VVHPEO\LQZLWKWKHYLVLRQWKDW³every patient receives safe healthcare, every 
time, everywhere´ (8). The NDOH in South Africa expects that implementation of such programmes will 
result in a reduction in the number and severity of patient safety incidents (9). This is needed as patient 
harm due to gaps in patient care is common across countries (10), causing many avoidable deaths 
each year as well as adding to costs (11-13). A large majority of these gaps are the unintended results 
of highly complex and imperfect healthcare delivery systems in which minor mishaps sometimes 
combine to cause harmful or disastrous results (9).  
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0HGLFDWLRQGLVFUHSDQFLHVDQGHUURUVDUHFRPPRQZKHQSDWLHQW¶VFURVV-organisational boundaries (10), 
and the lack of necessary information to patients, caregivers and healthcare providers, have resulted 
in an increase in medication discrepancies (14-16) ,QRUGHU WR LPSURYHSDWLHQWV¶VDIHW\ WKH:+2 
LQWURGXFHG WKH +LJK ¶V LQLWLDWLYH WRJHWKHU ZLWK WKH Joint Commission, which introduced medication 
reconciliation as a National Patient Safety Goal in 2006 (17-19). This comprised a process of 
systematically identifying the most complete and accurate list of the medication a patient is taking at 
home and comparing them with newly ordered medication in the hospital during admission, transfer and 
discharge (20,21). According to the Joint Commission (2006), this reconciliation is undertaken to avoid 
medication errors such as omissions, duplications, dosing errors, or drug interactions (19). It is 
recommended that the process should be undertaken at every transition of care in which new 
medications are ordered or existing orders are rewritten. Medication reconciliation is the process of 
obtaining and maintaining accurate and complete medication information for a patient, and using this 
information within and across the continuum of care to ensure safe and effective medication use (22). 
Studies have shown that for instance pharmacists and other professionals can play a role with improving 
medication reconciliation (23-25). Studies have shown that the monitoring of medication orders by 
clinical pharmacists may prevent more than half (58%) of all errors (26), with Kuo et al indicating that 
89% of clinical pharmacistV¶ recommendations were accepted by the prescribers to improve patient 
care (27).  
 
It is also recommended that to help improve the use of medicines, pharmacists should move onto the 
wards (28); however, this can be difficult especially in lower and middle income countries (LMICs) as 
this is time-consuming creating extra work for other staff when resources are limited. This must be 
balanced against published studies in public hospitals in South Africa finding 37 adverse events per 
DGPLVVLRQVZLWKRI WKHVHRFFXUULQJGXULQJ WKHSDWLHQW¶VKRVSLWDOLVDWLRQDQGEHLQJ
present on admission (29). Furthermore, more adverse events to medicines occur within hospitals, 
including those in South Africa, than are currently being reported through voluntary reporting systems 
(3, 30-33). This has increased the role of pharmacy technicians to improve patient safety through 
performing medication reconciliation (24,34). 
 
Standardised medication error databases to identify and quantify medication errors in hospitals are 
currently not available in South Africa. Voluntary reporting systems, as part of pharmacovigilance (PV) 
programmes, are though available (3). However, typically to date there has been under-reporting of 
ADRs in hospitals despite PV programmes being a National Standard (33,35-37). This is starting to be 
addressed through proactive educational initiatives (38).  
 
To the best of our knowledge, there is currently limited literature regarding the effectiveness of a 
medication reconciliation tool among public hospitals in South Africa to address current concerns. 
Consequently, the purpose of this study is to determine the effect of a pharmacist-driven medication 
reconciliation service implemented in specific wards at a leading academic tertiary hospital in South 
Africa during admission, transfer, and discharge of the patient, where currently there is no tool or system 
WR UHFRUG SDWLHQWV¶ PHGLFDWLRQ XSRQ DGPLVVLRQ DQG GLVFKDUJH RU D V\VWHP WR SHUIRUP PHGLFDWLRQ
reconciliation.  Subsequently, use this information to define the responsibility of public healthcare 
providers in South Africa and wider to enhance the identification of patient safety incidents and improve 
their management to minimise future patient harm and suffering, and to ensure where possible that 
medication errors are routinely investigated and managed to prevent repetition and to learn from prior 
mistakes (39). This is particularly important at this time in South Africa as it improves its public health 
system, including enhancing access to medicines in the public system for patients with chronic diseases 
(3,40). We also hope that the findings will also be of interest to other public hospitals in South Africa as 
well as other LMICs as they seek to improve care in their public hospitals.  
 
2. Methods 
 
2.1 Study design setting and population  
The research study followed a quantitative, descriptive study design. It was conducted prospectively at 
DGMAH over a nine-month period between September 2015 and June 2016. DGMAH is a rural public 
sector academic hospital (teaching facility) located in Ga-Rankuwa in the Gauteng Province of South 
Africa. It has 28 clinical departments, rendering all three levels of service and is one of four academic 
institutions in the Province. It is representative of other academic hospitals in the Province as well as 
the healthcare system in South Africa.  
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The study was conducted in the Internal Medicine and Surgical wards with a total of ±154 admissions 
per ward per month. This study included all participants over the age of 18 years old who took chronic 
medication at the time and for whom medications were prescribed in hospital. The ward characteristics 
are defined in further detail in Table 1. 
 
Table 1: Ward characteristics 
 
Unit 
Number 
of beds 
Number of 
admissions 
per month 
Occupancy 
Rate (%) 
Number of 
medications per 
ward 
Number of 
interventions 
   
Admission 
In-
hospital 
Admission 
In-
hospital 
Medical 128 150 85.33 205 333 97 130 
Surgical 180  100 180 263 459 161 164 
 
 
2.2 Definitions and key aspects of the study 
x Medication reconciliation: This is a process of systematically identifying the medications a patient 
is currently taking in their home and comparing them with newly ordered medications in the hospital 
(20). 
x Medication error: Any preventable event that occurs during any stage of the medication use 
process that may cause or lead to inappropriate medication use or patient harm while the 
medication is in the control of the healthcare professional, patient or consumer (41,42).  
Furthermore it can also be defined as ³Any preventable events that may cause or lead to 
LQDSSURSULDWHPHGLFDWLRQXVHRUSDWLHQWKDUP´.  
x Pharmaceutical care: The responsible provision of drug therapy for the purpose of achieving 
GHILQLWHRXWFRPHVWKDWLPSURYHDSDWLHQW¶VTXDOLW\RIOLIH43). It is further stated that it is based on a 
relationship between the patient and the healthcare providers, who accept responsibility to provide 
care to the patients, and involves the active participation of both the patient and the healthcare 
provider in drug therapy decisions (44). 
 
2.3 Study procedures 
Pharmaceutical care was rendered on a daily basis to all participants admitted to the Internal and 
Surgical wards of DGMAH. A data collection instrument (DCI) was adapted and developed from a 
number of studies in order to meet the objectives set out in this study (45,46). The form contained a 
SDWLHQWGDWDEDVHVKHHWWRFROOHFWGHPRJUDSKLFGDWDDQGDVHFWLRQWRHYDOXDWHWKHSDWLHQW¶VPHGLFDWLRQ
therapy, in order to identify potential and actual drug problems.    
 
This DCI was divided into three sections, which included:  
x Section 1: SDUWLFLSDQW¶V demographics, information about home medication and all the medication 
that was prescribed during admission and transfer of the patient, and if the medication was 
continued or discontinued upon discharge.  
x Section 2: SDUWLFLSDQW¶V home medication which included if he/she was taking any medication at 
home, if and how the patient brought their home medication to hospital as well as which resource 
the information was obtained from, e.g. patient, patient file, next of kin, or a healthcare professional. 
This section also included all the home medication names and if the medication is continued or 
discontinued upon admission and discharge. 
x Section 3: medication that was prescribed during admission and transfer of the patient, and if the 
medication was continued or discontinued upon discharge. The reason for discontinuation was 
recorded in this section.  
 
The data collection tool was used to review participants who met the following inclusion criteria: 
participants who were taking chronic medication at the time and for whom medications have been 
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prescribed in hospital, signed the consent form, and older than 18 years old.  For the first four months, 
the participants were selected by including all bed numbers that were even and for the second four 
months uneven bed numbers were included. All records were available as hard copies. 
 
Data (sources of medicines) included all prescription medication, herbal medication, nutritional 
supplements, over the counter (OTC) medication, vaccines, diagnostic and contrast agents, radioactive 
medications and parenteral nutrition. The recorded medication history was revised when the in-patient 
therapy was prescribed on the drug chart; and, upon the participants discharge, interventions were 
PDGHZLWKDQHZSURSRVHGGUXJWKHUDS\WKDWZDVFRPPXQLFDWHGYHUEDOO\WRWKHSDWLHQW¶VSK\VLFLDQDQG
the necessary changes were made in the form of a new reconciled medication list. Information had 
been recorded in the records according to usual practices of DGMAH.  
 
$OOWKHLQIRUPDWLRQREWDLQHGZDVFDSWXUHGLQD0LFURVRIW([FHOVSUHDGVKHHWDQGODWHULPSRUWHGWRWKH
Statistical Analysis System (SAS) (SAS Institute Inc, Carey New York City, United States of America), 
Release 9.3 for analysis. Descriptive analyses such as mean, median, mode and interquartile range 
were used to summarise the data. Demographic results were descriptive for age, sex, education, 
occupation and medication use. Frequencies, cross-tabs and measures of central tendency were used 
to compare medical record information. Results are presented in tables and graphs. A summary of the 
study procedure is illustrated in Figure 1. 
 
Figure 1: Data collection Process 
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2.4 Ethical considerations 
Data collection commenced after obtaining approval from the Sefako Makgatho Health Sciences 
University Research Ethics Committee (SMUREC/H/169/2015:PG) and permission and consent from 
DGMAH management. Informed consent from the participants or a family member was obtained and 
each participant was given an information leaflet if they required any further information.  All data were 
collected within the hospital environment and medical charts were not taken from the hospital premises. 
No patient or prescriber names or details were written on data collection forms or included in a Microsoft 
([FHOVSUHDGVKHHW1Rparticipants were identified or contacted, thus ensuring that anonymity and 
confidentiality were maintained. Confidentiality was also maintained during record reviews with the use 
of numerical identification of files and through the presentation of aggregate data and not individual 
data.  
 
3. Results 
 
3.1 Patient enrolment 
During the nine-month study period, 145 study participants from the Surgical and Internal Medicine 
wards were selected and enrolled on the basis of the inclusion criteria. A combination of an interview 
and review of the medical chart were used to determine the chronic medication patients were taking 
prior to admission. The medication was reviewed to identify any discrepancies. In total 1329 
medications were reviewed: 464 medications upon admission and 865 medications during the hospital 
stay.  
 
A total of 552 (41.53%) interventions were performed, of which 258 (55.60%) interventions were 
performed upon admission and 294 (40%) of the interventions were performed during WKHSDWLHQW¶V
hospital stay, with a statistical significance of p=0.012 (Pearson correlation and p= 0.006 Spearman 
correlation) (Figure 2).  
 
Figure 2 - Medication reconciliation process in the surgical and internal wards 
 
3.2 Patient Characteristics 
The majority of the participants were female (110 [75.86%]), with an average age of 54.4 years (range: 
18 to 86 years). The majority of the population (97.93%) was African. The population was divided 
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equally in terms of their occupational status: pensioners (37%), employed (32%) and unemployed 
(30%). The most common language spoken was Tswana (28.97%) followed by Sotho (17.93%) and 
Zulu (17.24%). Fewer than 2% (1.38%) of the study participants communicated in English. Less than 
half of the participants (42.66%) completed primary school and less than 12% (11.72%) continued to a 
college or training institute (Table 2).  
 
Table 2: Patient Characteristics 
 
 Number (n=145) Percentage (%) 
Gender 
Male 35 24.14 
Female 110 75.86 
Ethnic Group 
African 142 97.93 
Caucasian 3 2.07 
Language 
Tswana 42 28.97 
Sotho 26 17.93 
Zulu 25 17.24 
Tsonga 24 16.55 
Other  28 19.31 
Level of education 
Primary School 72 42.66 
High School 56 38.62 
College/training institute  17 11.72 
Occupation 
Employed 47 32.41 
Unemployed 44 30.34 
Pensioner 54 37.24 
 
3.3 Medication reconciliation on admission 
In total, 1329 medications were reviewed throughout the study with 464 (34.91%) upon admission. Over 
half (51.03%) of the study population did not bring their actual chronic medication to the hospital.    
 
Figure 3 illustrates how the remaining 48.9% of the participants brought their medication: either in the 
original packaging (40%), as single unidentified tablets/capsules (4.83%), repackaged and unlabelled 
(3.45%) or repackaged and labelled (0.69%). 
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Figure 3: Example of how patients brought their medication to the hospital 
 
 
Information obtained was not always conclusive upon interviewing the participants (due to sedation, 
poor understanding, or a language becoming a barrier for correct reconciliation to be undertaken). More 
than half (55.86 %) of the total participants required further investigation into the type of medicine taken 
by reviewing their medical charts (Table 3).  
 
Table 3: Sources of medication reconciliation 
 
Parameter Number (n=145) Percentage 
Source of medication reconciliation information 
Patient file 62 42.75 
Patient 81 55.86 
Next of kin 1 0.69 
Healthcare professional 1 0.69 
Medicines brought in from home 
Original Packaging 58 40 
Tablets/capsule as is 7 4.83 
Repackaged and labelled 1 0.69 
Repackaged and unlabelled 5 3.45 
None 74 51.03 
 
3.4 Review time 
The mean time to interview a participant/caregiver, as well as review a medical chart, was 16.4 (± 4.75) 
minutes (median (IQR): 15 (14-7KHWLPHWDNHQWRUHYLHZDSDWLHQW¶VPHGLFLQHLQFUHDVHGZLWKWKH
length of hospital stay to (13.6 (± 7.80)) days. Participants who were pensioners required more time 
(17.9 (± 5.24)) with the pharmacist. There is a significant difference in the time spent with employed 
participants compared to pensioners (p=0.001), also the time spent with self-employed participants 
compared with employed participants (p=0.005). There was no statistical significance (p=0.065) 
between the time spent with study participants with primary school education and those who received 
high school education or education at colleges/training institutes.  
 
The time taken to review a SDUWLFLSDQW¶V medicine decreased as the study progressed as the reviewer 
had more experience by the end of the study (Table 4). There is no statistical difference in the time 
spent on medication reconciliation during the different transitions of care. (r = 0.125, p=0.133), as well 
as the number of medications at the different points of care (r = 0.012, p=0.885). 
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Table 4: Time spent on medication reconciliation per occupation category 
 
Occupation n=145 Mean (± SD) p value Test 
Employed 
Mean (± SD) 
Median (IQR) 
31  
14.4 (± 2.89) 
15 (12 ± 15) 
0.001* 
A
N
O
V
A
 fo
llo
w
e
d
 by p
a
irw
ise
 t- te
s
ts 
Self-employed 
Mean (± SD) 
Median (IQR) 
16  
14.7 (± 4.06) 
15 (12 ± 17) 
0.0050* 
Unemployed 
Mean (± SD) 
Median (IQR) 
44  
16.5 (± 4.82) 
15 (14 ± 20) 
0.0050* 
Pensioner 
Mean (± SD) 
Median (IQR) 
54  
17.9 (± 5.24) 
17 (15 ± 22) 
0.001* 
Education 
College/Training Institute 
Mean (± SD) 
Median (IQR) 
17  
15.2 (± 4.72) 
15 (13-16) 
0.065 
A
N
O
V
A
 
High school 
Mean (± SD) 
Median (IQR) 
56  
15.6 (± 4.71) 
15(12-18) 
Primary school 
Mean (± SD) 
Median (IQR) 
72  
17.3 (± 4.70) 
15(15-20) 
Time spent on medication during the different transitions of care  
Number of medications on 
admission and time spent 
r 
rs 
   
Pearson 
correlation, 
Spearman 
correlation 
0.125  0.133 
0.157  0.058 
Number of medications in 
hospital and time spent 
r  
rs 
   
0.012  0.885 
0.013  0.878 
*Significantly different 
 
3.5 Medication used during hospital stay 
The medication used was classified according to the Anatomical Therapeutic Chemical (ATC) 
classification system (47-49).  A total of 1329 medicines were reviewed during the admission and 
discharge phase in hospital. More than half (50.8%) of the medication that patients brought with them 
from home was disclosed to the nursing staff. The total number of medicines brought into the hospital 
upon admission were 464, with an average of 3.2 medicines per patient on admission, and 865 
medications were prescribed with an average of six medications per patient during their hospital stay.   
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Table 5 indicates the different types of medication most frequently used, including medicines for the 
cardiovascular system (485 items; 35%), alimentary tract system (275 items; 21%) and anti-infective 
medicines (236 items; 18.1%).   
 
Table 5: Most frequently prescribed medicines 
 
Drug name Therapeutic class ATC Code Admission 
Frequency 
Number n= 
464 (%) 
In-hospital 
Frequency 
Number n= 
865 (%) 
Alimentary Tract and Metabolism 
Metformin Biguanide A10BA02 35 (7.33) 26 (3.00) 
Insulin Insulin A10AC01 10 (2.15) 24 (2.77) 
Cardiovascular System 
Amlodipine DHP-CCB C08CA01 23 (4.96) 39 (4.51) 
Enalapril ACE-inhibitor C09AA02 45 (9.70) 58 (6.71) 
Simvastatin HMG CoA 
Reductase Inhibitors 
C10AA01 15 (3.23) 25 (2.89) 
Furosemide High ceiling diuretic C03CA01 12 (2.59) 31 (3.58) 
HCTZ Low ceiling diuretic 
(thiazide) 
C03AA03 54 (11.64) 59 (6.82) 
Anti-invectives for systemic use 
Fixed dose combination 
of Anti-retrovirals: 
Efavirenz 
Tenofovir  
Emtricitabine 
Anti- retroviral J05AR06 
 
34 (7.33)  35(4.04) 
Isoniazid 
Rifampicin 
Ethambutol 
Pyrazinamide 
Anti-tuberculosis J04AM06 
 
23 (4.96) 52 (6.01) 
Antithrombotic agents 
Acetylsalicylic acid (aspirin)  Platelet aggregation 
inhibitor 
B01AC06 18 (3.88) 27 (3.12) 
>Analgesic 
Enoxaparin Low molecular 
weight heparin 
B01AB05 0 (0) 34 (3.93) 
Tramadol  Opioid N02AX02 6 (1.29) 56 (6.47) 
Analgesics and Antipyretic 
Paracetamol 
(Acetaminophen) 
Anilides N02BE01   17 (3.66) 44 (5.09) 
Traditional Medicine 
Traditional Medicine Traditional Medicine  5 (1.07) 0 
 
3.6 Interventions 
A significant difference between the admission and in-hospital prescription (r: r = 0.209, p: 0.0012) 
resulted in more interventions made during hospital stay (Table 6). 
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Table 6:  Intervention upon admission vs interventions during hospital stay 
 
 R and Rs  p value Test 
Intervention upon admission 
vs  
interventions during hospital 
stay 
r = 0.209,   
 
rs = 0.228 
p=0.0012*, 
 
p=0.006* 
Pearson correlation,       
 
Spearman correlation 
*Significant difference  
 
A total of 552 (41.53%) interventions were suggested for the 145 study participants during the different 
transitions of care (admission, in-hospital stay and discharge), with an average of 3.80 interventions 
per patient. More than 70% (79%) of all medicines were continued upon admission and nearly 40% 
(37.5%) of the medicines were discontinued during their hospital stay. The discontinuation of medicines 
upon admission was due to either the participant receiving the same or generic form of the medication 
in hospital, and the participant was unaware of this, or the healthcare staff were unware that the patient 
is continuing with their home medication even if it was prescribed in hospital.  'XULQJ WKHSDWLHQW¶V
hospital stay, the main reasons for discontinuation were either acute indications (24 %) or long-term 
use of a prophylactic medication, such as extended days of surgical antimicrobial prophylaxis (20%).  
 
In addition, more than 60% (66.12%) of medication was not transcribed to the hospital prescription 
forms, which resulted in medication omissions; consequently, patients did not receive their medication.  
A total of 294 (40%) interventions were made in hospital whereby over 30% (32.5%) of the participants 
required counselling as many did not know about their new medication.  Different types of interventions 
and examples of medication errors observed are shown in Table 7. 
 
Table 7: Types of interventions IRUSDWLHQW¶VPHGLFDWLRQGXULQJKRVSLWDOVWD\ and examples of 
interventions performed 
 
Intervention Percentage Examples of 
interventions 
performed 
p value Test 
Upon 
admission 
Upon hospital 
medication during 
hospital stay  
  F
ish
ers E
xa
ct T
e
st 
Alternative 
medication 
1.65 0.36 Patient was 
prescribed 
omeprazole for the 
treatment of peptic 
ulcers, however 
due to the lack of 
stock, ranitidine 
was issued for the 
time being 
0.103 
Change dose 0.83 2.85 Cloxacillin given as 
12 hourly instead of 
6 hourly as 
prescribed 
0.233 
Change 
frequency 
2.07 1.43 Patient was taking 
levodopa-carbidopa 
three times a day 
before admission 
but was ordered as 
twice daily during 
hospitalisation 
0.740 
Counselling 13.22 32.5 Patient was taking 
ibuprofen before 
½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admission, however 
patient continued to 
use own supply of 
ibuprofen while 
being treated for 
Upper Intestinal 
Gastric Bleed 
Monitor 
patient 
1.65 8.21 Patient is unaware 
of the new 
treatment, taking 
metformin without 
the knowledge of 
the healthcare staff 
while receiving 
insulin on a sliding 
scale resulting in 
low blood glucose 
levels 
½  
Stop the 
medication 
7.44 37.5 Patient is receiving 
Amoxicillin/clavulan
ic acid for 27 days 
with no signs of an 
infection 
½ 
Stop the 
medication 
and monitor 
the patient 
2.07 4.29 Patient complains 
about being dizzy. 
Upon investigation: 
patient is taking 
enalapril 10mg 
daily while 
receiving 5mg 
enalapril in hospital 
resulting in 
medication 
duplication and low 
BP 
0.846 
Transcribed to 
prescription 
66.12 11.07 Patient admitted to 
the internal 
medicine ward on 
ARV treatment, but 
during the hospital 
stay no ARV 
treatment was 
transcribed onto the 
hospital Rx 
½  
Use when 
necessary 
2.07 1.79 Patient was taking 
diclofenac, 50mg 
as needed before 
admission. While in 
hospital, patient 
continued to use 
own supply of 
diclofenac 
0.729 
*Significant difference 
 
4. Discussion 
 
The majority of the study population was African (97.93%) and more than half were female (75.86 %), 
which is in line with the general South African population (50).  Just under half (42.66%) of the study 
participants completed primary school and approximately 10% completed further training at a Tertiary 
12 
 
Training Institute. More than 30% (32.41%) of the participants were employed, contrary to the majority 
of South Africans, whereby nearly 60% of the population is employed (50).  
 
South Africa has eleven official languages. The study was conducted in Gauteng province and 
according to the 2011 census; the majority of the population in the province speak isiZulu, English and 
Afrikaans. Languages mostly spoken by the study participants included Tswana (28.97%), Sotho 
(17.93%) and Zulu (17.24%). This is important when interviewing patients on their medicine use in 
hospitals and other settings and countries where multiple languages are spoken. Otherwise, adherence 
can be compromised especially if patients do not understand the instructions (51-53).  
 
On admission, more than half of the study participants (51.03%) did not bring their home medication to 
the hospital. For the remaining study participants (48.97%), the majority of the medicines brought in 
were labelled, and in the original packaging, and consequently could be identified. This is very similar 
to a study performed in Brazil (54), where half of the patients (50%) brought their medication to the 
hospital on admission and close to 30% brought a list of medicines they were currently taking. The 
importance of reviewing actual medicines brought in by patients on admission by healthcare workers 
have also been highlighted in other studies (55).  
 
Medicines with the highest prevalence were those used for the cardiovascular system (35%), alimentary 
tract (21%) and anti-infectives (18.1%).  One would have expected the use of anti-infectives to be higher 
in South Africa, due to the AIDS pandemic and a recent rise in antimicrobial resistance (AMR) (56,57), 
which resulted in the recent instigation of national strategies to fight AMR (3, 58-61). However, South 
Africa has recently experienced a rise in non-communicable diseases (NCD), which include 
cardiovascular diseases, diabetes, cancers, chronic respiratory diseases and mental illness, resulting 
in initiatives to improve the availability of medicines to treat patients with chronic diseases as well as 
initiatives to enhance adherence rates (3,62-64).  In addition, in South Africa as in a number of other 
African countries, traditional healers play a role in healthcare. However, although there are more than 
200,000 traditional healers across the country (65), encouragingly less than 1.5% (1.07) of all the 
medicines brought in by the study participants were identified as traditional medicines. This though 
might not be an accurate reflection of traditional medicines used by the study participants, as published 
studies have shown that patients may be reluctant to disclose the use of traditional medicine because 
they fear disapproval and doctors do not always ask their patients about any traditional medicine use 
(66). 
 
In this study, sources of information about medicines being taken by patients included interviews with 
participants (55.86%) and medical chart reviews (42.75%). Medical chart reviews were not conducted 
in patients that were sedated, had either poor understanding of the study, or where language barriers 
(even with the help of an interpreter) could not be overcome. It has also been stated (67) that failure to 
communicate properly can have negative consequences such as patients may fail to comply with 
instructions or elect not to have potentially life-saving treatment. In addition, it is important to encourage 
the development of electronic recording systems to facilitate the tracking and easy retrieval of accurate 
information necessary for high-quality patient care (68,69). These are thoughts for the future as the 
uses of electronic recording systems grow across South Africa as well as other African countries.  
 
The average time to interview a patient as well as review a medical chart was 16.4 minutes. There was 
a significant difference (p=0.001) in the time spent interviewing employed participants and pensioners 
as typically pensioners enquired more about their medicines and typically required extra counselling 
such as side-effects and potential interactions. This is similar to a study performed in the United 
Kingdom whereby patient counselling took approximately 30 minutes more in pensioners in comparison 
to other age groups (70). The results from these studies suggest that in-patient counselling of elderly 
patients is a positive step to achieving maximum benefit from their medication and minimise 
unnecessary problems caused by excessive, inappropriate or inadequate consumption of medicines 
(70). Interestingly, there was no significant difference (p=0.065) in the time spent interviewing 
participants with primary school education although it took nearly two minutes longer (17.3 minutes) 
compared to participants who completed secondary or tertiary education (15.4 minutes). According to 
the 2012 General Household Survey (GHS) conducted by Statistics South Africa (50), 7.1% of South 
Africans are illiterate and this could result in more time being spent with patients with primary school 
education, as further clarification may be needed. Pharmacists can play a role with support and 
counselling for patients regarding their medicine use (70). 
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In this study, 1329 medicines were reviewed upon admission and during hospital stay. Discrepancies 
in medication history may impair the effectiveness and safety of medicines (47). There was a significant 
difference (p=0.006) when comparing the medicines patients were taking before or during 
hospitalisation; subsequently a total of 552 (41.53%) interventions were performed. The majority of 
patients had at least 3.96 medication discrepancies on average, which is high compared to studies 
conducted in countries such as the UK, USA and Canada which saw 0.93 -1.32 discrepancies per 
patient (71). When evaluating the origin of medication discrepancies, the most prevalent were omissions 
(medications used before admission but not transcribed during hospitalisation) which accounted for 
more than 60% (66.12%) of the interventions (Table 7). The predominance of omissions may be related 
to the collection of incomplete and inaccurate medication histories (54). Other studies have shown 
similar results, particularly with respect to a higher incidence of omissions (71-74), which needs to be 
addressed. 
 
$WRWDORIRIDOO LQWHUYHQWLRQVSHUIRUPHGZHUHGXULQJWKHSDWLHQWV¶KRVSLWDOVWD\RIZKLFK
required patient counselling as many participants did not know about the new treatment being 
prescribed. Over 35% (37.55%) of the interventions included discontinuing the previous treatment either 
due to an acute condition that had been resolved or the over-use of empiric therapy or extended 
antimicrobial prophylactic use. In addition, almost 14% (13.44%) of participants received duplicate 
therapy as they continued to take the same medicine prescribed in hospital (Table 7).  Duplication of 
medication may be attributed to the miscommunication between staff and participants, with many 
patients in this study unaware of which medicines were being prescribed or given to them, or they were 
unaware when their medicines were temporarily stopped; similar to other studies (75-78).  
 
This is a concern as the lack of patient education, communication, and transcribing home medication 
to prescription charts may result in treatment failure, poor prognosis and increased hospital stay (72).  
Furthermore, inadequate knowledge, insufficient training and increased workload of staff have also 
been listed as major causes of medicines discrepancies (76-78). Since physicians, nurses and 
pharmacists do play key roles in medication management, including ordering, monitoring and educating 
patients during hospitalisation, and at discharge, a multidisciplinary team approach is considered 
fundamental to enhance medication reconciliation, especially with errors often originating in medication 
histories (79). Applying medication reconciliation to the different stages of transitions can lead to better 
patient safety outcomes. The medication reconciliation tool used by pharmacists in this study was 
effective in identifying medication discrepancies and addressing these to improve patient safety. 
Consequently, multidisciplinary teams including pharmacists using such tools should become part of 
routine care in this and other public hospitals in South Africa. We will be following this in the future. 
 
5. Limitations 
We are aware that this study was conducted in only one leading academic public hospital. As a result, 
may not be fully representational of other teaching hospitals in South Africa. However, we intend to 
extend this study to other hospitals given the concerns identified, as well as use the findings to improve 
care within DGMAH. Performing medication reconciliation in a paper-based patient management 
system was also a challenge as not all patient files were neatly stored, which increased the time to 
review them. However, in view of our methodology, we believe our findings are robust providing 
direction to this and other public hospitals in South Africa. In addition, support the need for electronic 
systems within hospitals. 
 
6. Conclusion 
 
Medication reconciliation has the potential to bridge the communication gap between the 
healthcare team and the patient. Our study demonstrates that they are a number of issues with 
medication reconciliation throughout the hospitalization of patients that need to be addressed to 
improve patient care. This is because the lack of medication history and in-patient therapy led to a 
high number of necessary interventions in order to improve patient care and reduce errors.  Based on 
our findings, medication reconciliation practices by multidisciplinary teams, including pharmacists, 
should become routine especially in resource-limited settings such as South Africa to improve 
patient safety. To ensure continuity of patient care, medication reconciliation should be 
implemented throughout the SDWLHQW¶V hospital stay. Pharmacists are especially well suited to deal 
with these issues as they have in-depth knowledge on pharmacokinetics, pharmacodynamics, drug 
interactions and drug formulation. With this information, appropriate interventions will need to be 
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studied to reduce errors in the process of medication reconciliation. These are considerations for the 
future and we will be following this up. 
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